LENZ Therapeutics

Public

Solana Beach, CaliforniaHealthcarewww.lenz-tx.com

LENZ Therapeutics is now publicly traded

The data on this page reflects LENZ Therapeutics's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

PIPE

Jul 15, 2024

Total Funding Raised

$214M

Company Overview

LENZ Therapeutics operates in Healthcare and is based in Solana Beach, California. It has raised $214M.

LENZ Therapeutics (NAS: LENZ) is a biopharmaceutical company dedicated to developing and commercializing innovative therapies aimed at enhancing vision, with a primary focus on treating presbyopia, a common age-related decline in near vision affecting individuals over 45.

Sector

Healthcare

AI Layer

Non-AI

LENZ Therapeutics Comparables

Compare LENZ Therapeutics with similar companies based on industry and business-model similarity.

No comparables are published for LENZ Therapeutics. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

LENZ Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
PIPE	Jul 15, 2024	Demo	Demo	Demo	Demo
PIPE	Mar 21, 2024	Demo	Demo	Demo	Demo
Series B	Mar 7, 2023	Demo	Demo	Demo	Demo
Series A	Jun 17, 2021	Demo	Demo	Demo	Demo

Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Eef Schimmelpennink

President and CEO

Executive Team

For institutional investors. Book with your work email.

LENZ Therapeutics Investors

Notable investors and investment history

LENZ Therapeutics investors
Investor	Rounds
RA Capital Management	Series A, Series B, PIPE
Ridgeback Capital	PIPE
Versant Ventures	Series A, Series B, PIPE
Sectoral	Series B
RTW Investments	PIPE, Series B
Samsara BioCapital	PIPE
Alpha Wave Global	Series B, PIPE